"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial"
"Interpretation
Our findings suggest that cannabidiol might reduce seizure frequency and might have an adequate safety profile in children and young adults with highly treatment-resistant epilepsy. Randomised controlled trials are warranted to characterise the safety profile and true efficacy of this compound."
http://lancet.com/journals/laneur/article/PIIS1474-4422(15)00379-8/abstract
No comments:
Post a Comment